Company Filing History:
Years Active: 2012
Title: Kitamura Yoritaka: Innovator in Medical Devices
Introduction
Kitamura Yoritaka is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medical devices, particularly with his innovative designs that enhance patient care. His work exemplifies the intersection of technology and healthcare, showcasing the importance of innovation in improving medical practices.
Latest Patents
Kitamura holds a patent for a lancet assembly and pricking device. This device includes a lancet and a lancet holder that houses the lancet. The lancet features a body, a cap, and a pricking component. The pricking component is situated within both the lancet body and the cap. The tip of the pricking component is covered by the lancet cap. When the lancet cap is pressed in the pricking direction while attached to the holder, a bridging component breaks, separating the cap from the body. This design allows for a more efficient and safer pricking process, which is crucial in medical applications.
Career Highlights
Kitamura is associated with Izumi-Cosmo Company, Limited, where he continues to develop innovative medical solutions. His work has garnered attention for its practicality and effectiveness in real-world applications. He has successfully navigated the complexities of patenting his inventions, ensuring that his contributions to the medical field are protected and recognized.
Collaborations
Kitamura has worked alongside talented colleagues, including Abe Teruyuki and Seki Kazuharu. Their collaborative efforts have fostered an environment of innovation and creativity, leading to advancements in medical technology.
Conclusion
Kitamura Yoritaka's contributions to the field of medical devices highlight the importance of innovation in healthcare. His patented lancet assembly demonstrates a commitment to improving patient care through technology. As he continues to work with his colleagues at Izumi-Cosmo Company, Limited, the future of medical innovation looks promising.